Physician profile
Glendon Markollari
NPI 1821984626
$358.22
in general payments reported to CMS, 2019-2025
11 companies · $358 in 2025
The $358 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.23 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $99.99 | 2025 | |
| Medtronic, INC. | $58.29 | 2025 | Altaviva |
| Karl Storz Endoscopy-America | $34.20 | 2025 | N.A. |
| Olympus America INC. | $26.06 | 2025 | |
| Endo USA, INC. | $24.37 | 2025 | Xiaflex |
| Vertex Pharmaceuticals Incorporated | $24.27 | 2025 | |
| Coloplast Corp | $24.22 | 2025 | |
| Tolmar, INC. | $18.51 | 2025 | Jatenzo |
| Ethicon US, LLC | $17.70 | 2025 | Monocryl, Vicryl, Prolene |
| Abc Home Medical Supply, INC. | $15.84 | 2025 | |
| Janssen Pharmaceuticals, INC | $14.77 | 2025 | N/A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glendon Markollari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.